Correlation Between Taxus Cardium and Blueprint Medicines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Taxus Cardium and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taxus Cardium and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taxus Cardium Pharmaceuticals and Blueprint Medicines Corp, you can compare the effects of market volatilities on Taxus Cardium and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taxus Cardium with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taxus Cardium and Blueprint Medicines.

Diversification Opportunities for Taxus Cardium and Blueprint Medicines

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Taxus and Blueprint is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Taxus Cardium Pharmaceuticals and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Taxus Cardium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taxus Cardium Pharmaceuticals are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Taxus Cardium i.e., Taxus Cardium and Blueprint Medicines go up and down completely randomly.

Pair Corralation between Taxus Cardium and Blueprint Medicines

If you would invest  8,893  in Blueprint Medicines Corp on October 20, 2024 and sell it today you would earn a total of  2,112  from holding Blueprint Medicines Corp or generate 23.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy5.0%
ValuesDaily Returns

Taxus Cardium Pharmaceuticals  vs.  Blueprint Medicines Corp

 Performance 
       Timeline  
Taxus Cardium Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Taxus Cardium Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Taxus Cardium is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Blueprint Medicines Corp 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Blueprint Medicines Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, Blueprint Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.

Taxus Cardium and Blueprint Medicines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Taxus Cardium and Blueprint Medicines

The main advantage of trading using opposite Taxus Cardium and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taxus Cardium position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.
The idea behind Taxus Cardium Pharmaceuticals and Blueprint Medicines Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum